Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $66,016 | $65,845 | $64,225 | $114,701 |
| - Cash | $13 | $8 | $6 | $18 |
| + Debt | $65 | $43 | $52 | $62 |
| Enterprise Value | $66,068 | $65,879 | $64,270 | $114,744 |
| Revenue | $188 | $135 | $201 | $129 |
| % Growth | 39.2% | -32.7% | 55.7% | – |
| Gross Profit | $131 | $86 | $140 | $49 |
| % Margin | 69.5% | 63.9% | 69.8% | 38.3% |
| EBITDA | -$75 | -$107 | -$37 | -$138 |
| % Margin | -39.6% | -79.3% | -18.6% | -106.6% |
| Net Income | -$116 | -$130 | -$54 | -$184 |
| % Margin | -61.4% | -96.3% | -27% | -142.7% |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.002 |
| % Growth | 14.3% | -133.3% | 68.4% | – |
| Operating Cash Flow | -$18 | $11 | -$1 | $3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$18 | $11 | -$1 | $3 |